Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

Shares of Illumina Inc. (NASDAQ:ILMN) dropped 3.8% on Wednesday after Citi downgraded the stock from Neutral to Sell, warning ...

The Global Cytogenetics Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 9.5% over the forecast period 2024-2032. Request To ...

The Global Biochips Market is valued at approximately USD 17.09 billion in 2023 and is expected to grow with a robust CAGR of 11.2% over the forecast period 2024-2032. Request To Download Free Sample ...

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

According to a comprehensive market research report titled "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering ...

Explore the future of proteomics where new biomarkers are redefining disease, possibly outpacing genomics. With venture capital backing and double-digit growth, the market forecasts suggest ...

Macroeconomic developments and geopolitical issues, especially concerning China, have led to adjustments in full-year 2025 projections. Despite these headwinds, some analysts believe that Illumina’s ...